Benzinga | Aug 24, 2020 06:09AM EDT

HC Wainwright & Co. Maintains Buy on Repligen, Raises Price Target to $168

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Repligen (NASDAQ:RGEN) with a Buy and raises the price target from $151 to $168.